Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and personalized treatment are crucial for managing pediatric androgenetic alopecia.

Androgenetic alopecia can be treated with minoxidil and finasteride, requiring long-term use and patient cooperation.

Thyroid receptor β can help develop new drugs to treat hair loss.

New treatment using Minoxidil and EGCG with ionic liquids improves hair growth and quality for hair loss.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Adding stromal vascular fraction to platelet-rich plasma injections did not significantly improve hair growth in androgenetic alopecia treatment.

Natural compounds from Chinese herbs may safely promote hair growth and treat common hair loss.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

PON1 levels might indicate hair loss severity, but other health factors can affect this.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

No significant link between hair loss and iron or thyroid levels was found, but checking for deficiencies might still be useful.

Substances from fat-derived stem cells can promote hair growth and counteract hormone-related hair loss by activating a key hair growth pathway.

The scalp fat tissue of men with hair loss shows changes in gene activity that may contribute to their condition.

Cellcurin therapy with microneedling increases hair density and thickness in treating hair loss in men and women.

More personalized and effective treatments for androgenetic alopecia are needed.

Using different hair loss treatments at various times can improve results and reduce side effects for people with chronic hair loss.

TGFβ-2 may cause hair loss in androgenetic alopecia.

ADSC-Exos with miR-122-5p can help treat hair loss by promoting hair growth.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

The combined treatment improved scalp health in women with early-stage hair loss.

Dutasteride improved both hair loss and acne in two young men.

Targeting a protein that blocks hair growth with microRNAs could lead to new hair loss treatments, but more research is needed.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

Camellia seed cake extract may help hair growth by blocking the hair loss effects of a hormone called DHT.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Trichoscopy, a hair loss evaluation technique, found that people with Androgenetic Alopecia have more thin hairs, yellow dots, and perifollicular discoloration than healthy individuals.

Using both minoxidil and platelet-rich plasma therapy together is more effective for hair growth in women than using minoxidil alone.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.